| |
Adjusted Odds ratio |
95% CI |
P-value |
| Age ≤ 40 years |
1.67 |
0.69 - 4.05 |
0.25 |
| Baseline CD4 cell count <200 cells/µL |
0.85 |
0.36 - 2.01 |
0.72 |
| Baseline hemoglobin <10 g/dl |
3.50 |
1.47 - 8.36 |
0.005 |
| Baseline WHO clinical stage 3-4 |
9.49 |
4.20 - 21.42 |
<0.0001 |
| Current BMI <25 Kg/m2 |
1.06 |
0.51 - 2.20 |
0.86 |
| Current CD4 cell count <200 cells/µL |
3.43 |
1.49 - 7.92 |
0.003 |
| Current hemoglobin <10 g/dl |
0.55 |
0.16 - 1.91 |
0.34 |
| Duration of HIV diagnosis <3 years |
2.30 |
0.79 - 6.67 |
0.12 |
| Female gender |
1.03 |
0.41 - 2.55 |
0.95 |
| HAART non-adherence |
5.28 |
2.52 - 11.08 |
<0.0001 |
| HAART duration <36 months |
0.99 |
0.35 - 2.85 |
0.99 |
| Household income < 20,000 |
2.70 |
1.18 - 6.18 |
0.02 |
| People per room >2 |
1.11 |
0.49 - 2.53 |
0.80 |
| Rural residence |
0.98 |
0.46 - 2.07 |
0.95 |
| Lower socio-economic class |
0.70 |
0.31 - 1.62 |
0.41 |
BMI= body mass index; HAART= highly active antiretroviral therapy; WHO= world health organization